1/26
Comprehensive vocabulary flashcards covering the discovery, features, targets, mechanisms of action, and resistance mechanisms of antibacterial medications.
Chemotherapeutic agents
Chemicals used to treat disease; in modern usage, specifically refers to chemicals toxic to humans that preferentially affect fast-growing or cancerous cells.
Antimicrobial drugs
Chemotherapeutic agents that have antimicrobial activity.
Selective toxicity
The property of medically useful antimicrobial drugs to cause greater harm to microbes than to their human host by interfering with essential processes common among bacteria but not human cells.
Therapeutic index
The measure of a drug's relative toxicity, expressed as the lowest dose toxic to the patient divided by the dose typically used for therapy (therapeutic index=therapeutic doselowest toxic dose).
Bacteriostatic drugs
Medications that inhibit bacterial growth and rely on the host immune system to clear the infection; examples include sulfa drugs, tetracycline, and chloramphenicol.
Bactericidal drugs
Medications that actively kill bacteria; the preferred treatment option for young, elderly, or immunocompromised patients; examples include penicillins and cephalosporins.
β-lactam drugs
A class of antibacterial medications (including penicillins) that competitively inhibit enzymes (PBPs) forming peptide bridges between adjacent glycan chains, disrupting cell wall synthesis and causing osmotic lysis.
Penicillin-binding proteins (PBPs)
The group of enzymes that catalyze the formation of peptide bridges between adjacent glycan strands in the final steps of peptidoglycan synthesis, for which penicillin competitively binds.
Vancomycin
An intravenous antibacterial drug considered an 'antibiotic of last resort' that binds to the amino acid side chain of NAM molecules to block peptidoglycan synthesis in Gram-positive bacteria and severe C.difficile infections.
Bacitracin
An antibacterial drug that interferes with cell wall synthesis by blocking the transport of peptidoglycan precursors across the cytoplasmic membrane.
Beta-lactamase
A horizontally transferable bacterial enzyme that confers drug resistance by breaking the β-lactam ring common to all members of the β-lactam class.
Penicillinase
A specific bacterial enzyme that breaks down and inactivates penicillins.
Augmentin
A combination therapy medication containing amoxicillin and clavulanic acid, where clavulanic acid acts as a β-lactamase inhibitor to block bacterial resistance.
Polymyxin B and Daptomycin
Antibacterial medications that target and disrupt bacterial cell membrane integrity.
Fluoroquinolones and Rifamycins
Antibacterial medications that target bacterial nucleic acid synthesis.
Aminoglycosides
Antibacterial medications that bind to the 30S ribosomal subunit to block the initiation of translation and cause the misreading of mRNA.
Tetracyclines and glycylcyclines
Antibacterial medications that bind to the 30S ribosomal subunit and block the attachment of tRNA to the ribosome.
Chloramphenicol
A bacteriostatic antibacterial medication that binds to the 50S ribosomal subunit and prevents peptide bonds from being formed during protein synthesis.
Macrolides
Antibacterial medications that bind to the 50S ribosomal subunit to prevent the continuation of protein synthesis.
Lincosamides
Antibacterial drugs that bind to the 50S ribosomal subunit and inhibit protein synthesis by preventing elongation.
Oxazolidinones
Antibacterial medications that bind to the 50S ribosomal subunit and interfere with the initiation of protein synthesis.
Streptogramins
Antibacterial medications binding to the 50S subunit in which each component drug interferes with a distinct step of protein synthesis.
Sulfonamides (Sulfa drugs)
Antimicrobial antimetabolites structurally similar to para-aminobenzoic acid (PABA) that inhibit the first enzyme in the folate biosynthesis pathway, blocking nucleotide synthesis.
Trimethoprim
An antimicrobial drug that inhibits enzyme #3 in the folate pathway, halting the conversion of dihydrofolate to tetrahydrofolate and blocking thymine, guanine, and adenine production.
Efflux pumps
Transport proteins in resistant bacterial cells that mediate increased elimination by ejecting the antimicrobial drug after it enters the cell.
Porin proteins (in drug resistance)
Outer membrane protein channels whose alteration causes decreased uptake of antimicrobial drugs by preventing their entry into the bacterial cell.
Alteration in target molecule
A mechanism of acquired resistance where a structural change in the bacterial target prevents the antimicrobial drug from binding to it.